Christina Farr

Christina Farr

Christina Farr is a healthcare writer and investor. Formerly at CNBC and Reuters, she covers digital health, startups, and policy, blending reporting with analysis and investing perspective to help leaders navigate healthcare’s evolving landscape.

New York City · 271 posts

Are there better alternatives to Ozempic with Sami Inkinen, CEO of Virta Health

Are there better alternatives to Ozempic with Sami Inkinen, CEO of Virta Health

Christina Farr March 19, 2025

This week on Second Opinion, we're featuring Christina Farr, Ash Zenooz, and Luba Greenwood's conversation with Sami Inkinen, CEO of Virta Health.

4 questions on the future of employer-sponsored healthcare

4 questions on the future of employer-sponsored healthcare

Christina Farr March 14, 2025 7 min read

What is keeping employers up at night going into 2025? A conversation with Chris Michalak

Why health care entrepreneurs need to be missionaries, not mercenaries — with angel investor Zen Chu

Why health care entrepreneurs need to be missionaries, not mercenaries — with angel investor Zen Chu

Christina Farr March 12, 2025

This week on Second Opinion, Christina Farr sits down with healthcare investing legend Zen Chu, who shares his framework for backing resilient entrepreneurs and insights from early investments in companies like Abridge and PillPack.

Why the Hinge Health IPO is so important for digital health

Premium

Why the Hinge Health IPO is so important for digital health

Christina Farr March 11, 2025 6 min read

A few thoughts...

Why is longevity suddenly so hot?

Premium

Why is longevity suddenly so hot?

Christina Farr March 6, 2025 9 min read

Between Function Health, Lifeforce and Superpower, this space is on fire

Is health-tech entering its ‘influencer’ era?

Is health-tech entering its ‘influencer’ era?

Christina Farr February 27, 2025 7 min read

And what are the pros and cons?

Distribution advantage: Are influencers the new moat in healthcare? with Headline VC's Georgina McMillan

Distribution advantage: Are influencers the new moat in healthcare? with Headline VC's Georgina McMillan

Christina Farr February 26, 2025

The week on Second Opinion, Christina Farr and Luba Greenwood sit down with Georgina McMillan to discuss the impact of

4 questions on President Trump and IVF

4 questions on President Trump and IVF

Christina Farr February 20, 2025 4 min read

I caught up with Conceivable Life Sciences’ Joshua Abram to understand the political landscape and its impact on reproductive health

Care delivery in all 50 states? No longer as common as it used to be

Premium

Care delivery in all 50 states? No longer as common as it used to be

Christina Farr February 12, 2025 4 min read

Some digital health companies are getting more targeted with their approach

Let's talk about men's health: hormones, longevity, and cultural shifts, with Hone CEO Saad Alam

Let's talk about men's health: hormones, longevity, and cultural shifts, with Hone CEO Saad Alam

Christina Farr February 5, 2025

In this episode of Second Opinion, Christina Farr and Luba Greenwood discuss men's health with Saad Alam, co-founder and CEO of Hone Health.

Dr. Dean Ornish proved heart disease Is reversible. Now he's doing it with Alzheimer's

Dr. Dean Ornish proved heart disease Is reversible. Now he's doing it with Alzheimer's

Christina Farr January 29, 2025

What Dr. Dean Ornish is showing the establishment about disease reversal

There’s a new game in town for D2C health business models

Premium

There’s a new game in town for D2C health business models

Christina Farr January 27, 2025 7 min read

And it’s rapidly evolving in real time!